Accueil > Actualité
Actualite financiere : Actualite bourse

Roche: collaboration agreement with Ascidian Therapeutics

( - US biotech Ascidian Therapeutics announced on Tuesday the signature of a collaboration and licensing agreement with Swiss pharmaceutical giant Roche.

Under the terms of the partnership, both groups will work together on the development of RNA exon editing technologies to discover new treatments for neurological diseases.

Ascidian will conduct research and pre-clinical studies in cooperation with Roche, which will be responsible for clinical development, manufacturing and commercialisation.

Ascidian will receive an upfront payment of $42m, but could receive up to $1.8bn in milestone payments and potential royalties on future sales of products resulting from the collaboration.

Copyright (c) 2024 All rights reserved.




Qui sommes-nous ? | Nous contacter | FAQ | Mentions légales | RSS | © Copyright 2007 Cercle Finance. Tous droits réservés.